The Public Investment Fund (PIF) announced today, June 19, the launch of Expo 2030 Riyadh Co. (ERC), a wholly owned subsidiary tasked with developing ...

The decision to move into phase 3 testing follows the completion of various phase 1 studies that backed the drug's safety, tolerability, and pharmacokinetics, according to Roche. The drug ...